Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.12.2022 | Case report

Tobramycin/vancomycin

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Schoeffel J, et al. Successful Use of Salvage Bacteriophage Therapy for a Recalcitrant MRSA Knee and Hip Prosthetic Joint Infection. Pharmaceuticals 15: 1-7, No. 2, 31 Jan 2022. Available from: URL: http://doi.org/10.3390/ph15020177 Schoeffel J, et al. Successful Use of Salvage Bacteriophage Therapy for a Recalcitrant MRSA Knee and Hip Prosthetic Joint Infection. Pharmaceuticals 15: 1-7, No. 2, 31 Jan 2022. Available from: URL: http://​doi.​org/​10.​3390/​ph15020177
Metadaten
Titel
Tobramycin/vancomycin
Lack of efficacy: case report
Publikationsdatum
01.12.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-29178-z

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Tadalafil

Case report

Methotrexate